Recent research from Duke University has demonstrated a promising new approach that could be used to treat a rare and complex ...

A single genetic switch could potentially treat a rare but severe childhood disorder. Prader-Willi Syndrome (PWS) affects approximately 1 in 15,000 newborns, causing insatiable hunger, obesity ...

The US government has provided almost $24 million in funding to Locus Biosciences to support a mid-stage trial of LBP-EC01, a CRISPR-engineered bacteriophage therapy in development for resistant ...

called “spacers” into the CRISPR locus in the genome of the bacterial host. These spacers are later transcribed into crRNA that are loaded on Cas nucleases to target them to cleave and block recurring ...

Locus is no exception. It’s developing what is known as Type 1 CRISPR-Cas3-enhanced bacteriophage therapeutics. Locus starts with naturally occurring bacteriophages (phages) that infect and replicate ...

1 At conferences like Pittcon, where analytical chemistry and life science collide, CRISPR’s growing influence is unmistakable, taking a prominent place in the Bioanalytical & Life Sciences and ...